Study Comparing One Versus Two Cortisone Injections for Trigger Finger
Status unconfirmed · Not applicable
Conditions studied: Stenosing Tenosynovitis, Trigger Finger
In brief
Trigger finger, also known as stenosing tenosynovitis, is a painful condition that can cause discomfort and disability. Many physicians choose to locally inject cortisone into the infected finger although there is no current consensus as to how many injections are needed to achieve maximum relief. This study will be a prospective, randomized study to compare one versus two injections for the treatment of trigger finger.
Key facts
- Study ID
- NCT00951236
- Run by
- Rothman Institute Orthopaedics
- People needed
- 392
- Starts
- 2009-05-01
- Last updated by the study team
- 2014-02-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject is greater than 18 years of age, presenting with stenosing tenosynovitis.
- Subject is willing and able to provide informed consent.
You may not qualify if…
- Patients who have previously undergone surgery for the treatment of trigger finger.
Where it is running
- Rothman Institute: Egg Harbor Township Location — Egg Harbor, New Jersey, United States (enrolling)
- Rothman Institute: Manahawkin location — Manahawkin, New Jersey, United States (enrolling)
- Rothman Institute: Vorhees location — Vorhees, New Jersey, United States (enrolling)
- Rothman Institute: Media location — Media, Pennsylvania, United States (enrolling)
- Rothman Institute Center City Location — Philadelphia, Pennsylvania, United States (enrolling)
- Rothman Institute, South Philadelphia Location — Philadelphia, Pennsylvania, United States (enrolling)
- Rothman Institute, Northeast Philadelphia location — Philadelphia, Pennsylvania, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.